Literature DB >> 18979225

Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1.

Sheng-Hua Chu1, Dong-Fu Feng, Yan-Bin Ma, Zhi-An Zhu, Hong Zhang, Jian-Hua Qiu.   

Abstract

Hypoxia regulates expression of hepatocyte growth factor (HGF) by increasing its transcription and by stabilizing its mRNA. Despite the pivotal role of hypoxia-inducible factor 1 (HIF-1) in transcriptional activation of hypoxia-responsive genes, it is not known whether HIF-1 mediates hypoxia-induced stabilization of HGF mRNA. We constructed adenoviral vectors expressing either the wild-type HIF-1alpha (Ad2/HIF-1alpha/FL), a constitutively stable hybrid form of HIF-1alpha (Ad2/HIF-1alpha/VP16), or no transgene (Ad2/CMVEV). In rat glioma (C6) cells, human glioma (U251) cells human cardiac, vascular smooth muscle, and endothelial cells, infection with Ad2/HIF-1alpha/VP16 or Ad2/HIF-1alpha/FL increased HGF expression at both the mRNA and protein levels. Under normoxic conditions, the half-life of HGF mRNA was 43 min in C6 and U251 cells. Hypoxia and Ad2/HIF-1alpha/VP16 increased the half-life of HGF mRNA to 3.2 and 2.8 h, respectively, while Ad2/CMVEV had no effect. These studies are the first to demonstrate that overexpression of HIF-1alpha increases HGF mRNA stability. Our results also suggest that stabilization of HGF mRNA by hypoxia is mediated, at least in part, by HIF-1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18979225     DOI: 10.1007/s11033-008-9406-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  55 in total

1.  Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: the roles of p38, ERK, and JNK MAPK signaling.

Authors:  Troy A Markel; Paul R Crisostomo; Meijing Wang; Christine M Herring; Tim Lahm; Kirstan K Meldrum; Keith D Lillemoe; Frederick J Rescorla; Daniel R Meldrum
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-01-04       Impact factor: 4.052

2.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.

Authors:  Takao Ide; Yoshihiko Kitajima; Atsushi Miyoshi; Takao Ohtsuka; Mayumi Mitsuno; Kazuma Ohtaka; Yasuo Koga; Kohji Miyazaki
Journal:  Int J Cancer       Date:  2006-12-15       Impact factor: 7.396

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells.

Authors:  Benedetta Peruzzi; Gagani Athauda; Donald P Bottaro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

Review 7.  Oxygen sensing and molecular adaptation to hypoxia.

Authors:  H F Bunn; R O Poyton
Journal:  Physiol Rev       Date:  1996-07       Impact factor: 37.312

8.  [The expression of hepatocyte growth factor and its receptor in brain astrocytomas].

Authors:  Sheng-Hua Chu; Xian-Hou Yuan; Pu-Cha Jiang; Zhi-Qiang Li; Jie Zhang; Zhi-Hua Wen; Shi-Yu Zhao; Xin-Jun Chen; Chang-Jun Cao
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2005-03-30

9.  Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.

Authors:  Christian Parr; Wen G Jiang
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  13 in total

Review 1.  The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Authors:  Alphonse E Sirica
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-29       Impact factor: 46.802

2.  Regulation of hepatocyte growth factor expression by NF-κB and PPARγ in adipose tissue.

Authors:  Jun Yin; Jong Han Lee; Jin Zhang; Zhanguo Gao; Vsevolod Y Polotsky; Jianping Ye
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-02-25       Impact factor: 4.310

3.  Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells.

Authors:  Ling Zhang; Wei Ge; Ke Hu; YanYan Zhang; ChangHu Li; XiMing Xu; Du He; ZhenYu Zhao; JinZhong Zhang; FangFang Jie; Yu Chen; YongFa Zheng
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

4.  In vitro and in vivo radiosensitization of human glioma U251 cells induced by upregulated expression of SLC22A18.

Authors:  S-H Chu; Z-M Zhou; S Karri; Z-Q Li; J-M Zhao
Journal:  Cancer Gene Ther       Date:  2014-01-31       Impact factor: 5.987

Review 5.  Targeting hypoxic response for cancer therapy.

Authors:  Elisa Paolicchi; Federica Gemignani; Marija Krstic-Demonacos; Shoukat Dedhar; Luciano Mutti; Stefano Landi
Journal:  Oncotarget       Date:  2016-03-22

6.  Phase I/II Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers.

Authors:  Keith T Flaherty; Betty K Hamilton; Mark A Rosen; Ravi K Amaravadi; Lynn M Schuchter; Maryann Gallagher; Helen Chen; Chandra Sehgal; Peter J O'Dwyer
Journal:  Oncologist       Date:  2015-06-17

7.  Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma.

Authors:  Yong Qin; Jason Roszik; Chandrani Chattopadhyay; Yuuri Hashimoto; Chengwen Liu; Zachary A Cooper; Jennifer A Wargo; Patrick Hwu; Suhendan Ekmekcioglu; Elizabeth A Grimm
Journal:  Mol Cancer Ther       Date:  2016-07-25       Impact factor: 6.261

Review 8.  The PARP Enzyme Family and the Hallmarks of Cancer Part 2: Hallmarks Related to Cancer Host Interactions.

Authors:  Máté A Demény; László Virág
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

9.  Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo.

Authors:  Sheng-Hua Chu; Dong-Fu Feng; Yan-Bin Ma; Zhi-Qiang Li
Journal:  Int J Nanomedicine       Date:  2012-07-12

10.  Conditional genetic elimination of hepatocyte growth factor in mice compromises liver regeneration after partial hepatectomy.

Authors:  Kari Nejak-Bowen; Anne Orr; William C Bowen; George K Michalopoulos
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.